Usage: Jevtana (cabazitaxel) is used with prednisone to treat metastatic castration-resistant prostate cancer in adults previously treated with a docetaxel-based regimen.
Usage: ZYTIGA (abiraterone), with prednisone, treats metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC) in adults.